Probing the interaction between inactivation gating and D-sotalol block of HERG

Hirotaka Numaguchi, Franklin M. Mullins, J. P. Johnson, David C. Johns, Sunny S. Po, Iris C.H. Yang, Gordon F. Tomaselli, Jeffrey R. Balser

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Potassium channels encoded by HERG underlie I(Kr), a sensitive target for most class III antiarrhythmic drugs, including methanesulfonanilides such as D-sotalol. Recently it was shown that these drugs are trapped in the channel as it closes during hyperpolarization. At the same time, HERG channels rapidly open and inactivate when depolarized, and methanesulfonanilide block is known to develop in a use-dependent manner, suggesting a potential role for inactivation in drug binding. However, the role of HERG inactivation in class III drug action is uncertain: Pore mutations that remove inactivation reduce block, yet many of these mutations also modify the channel permeation properties and could alter drug affinity through gating-independent mechanisms. In the present study, we identify a definitive role for inactivation gating in D-Sotalol block of HERG, using interventions complementary to mutagenesis. These interventions (addition of extracellular Cd2+, removal of extracellular Na+) modify the voltage dependence of inactivation but not activation. In normal extracellular solutions, block of HERG current by 300/μmol/L D-sotalol reached 80% after a 10-minute period of repetitive depolarization to +20 mV. Maneuvers that impeded steady-state inactivation also reduced D-sotalol block of HERG: 100 μmol/L Cd2+ reduced steady-state block to 55% at +20 mV (P<0.05); removing extracellular Na+ reduced block to 44% (P<0.05). An inactivation-disabling mutation (G628C-S631C) reduced D-sotalol block to only 11% (P<0.05 versus wild type). However, increasing the rate of channel inactivation by depolarizing to +60 mV reduced D-sotalol block to 49% (P<0.05 versus +20 mV), suggesting that the drug does not primarily bind to the inactivated state. Coexpression of MiRP1 with HERG had no effect on inactivation gating and did not modify D-sotalol block. We postulate that D-sotalol accesses its receptor in the open pore, and the drug-receptor interaction is then stabilized by inactivation. Whereas deactivation traps the bound methanesulfonanilide during hyperpolarization, we propose that HERG inactivation stabilizes the drug-receptor interaction during membrane depolarization.

Original languageEnglish (US)
Pages (from-to)1012-1018
Number of pages7
JournalCirculation Research
Volume87
Issue number11
DOIs
StatePublished - Nov 24 2000
Externally publishedYes

Fingerprint

Sotalol
Drug Receptors
Pharmaceutical Preparations
Drug Interactions
Mutation
Anti-Arrhythmia Agents
Potassium Channels
Mutagenesis
Membranes

Keywords

  • Antiarrhythmic drugs
  • HERG
  • Inactivation
  • Potassium channel

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Numaguchi, H., Mullins, F. M., Johnson, J. P., Johns, D. C., Po, S. S., Yang, I. C. H., ... Balser, J. R. (2000). Probing the interaction between inactivation gating and D-sotalol block of HERG. Circulation Research, 87(11), 1012-1018. https://doi.org/10.1161/01.RES.87.11.1012

Probing the interaction between inactivation gating and D-sotalol block of HERG. / Numaguchi, Hirotaka; Mullins, Franklin M.; Johnson, J. P.; Johns, David C.; Po, Sunny S.; Yang, Iris C.H.; Tomaselli, Gordon F.; Balser, Jeffrey R.

In: Circulation Research, Vol. 87, No. 11, 24.11.2000, p. 1012-1018.

Research output: Contribution to journalArticle

Numaguchi, H, Mullins, FM, Johnson, JP, Johns, DC, Po, SS, Yang, ICH, Tomaselli, GF & Balser, JR 2000, 'Probing the interaction between inactivation gating and D-sotalol block of HERG', Circulation Research, vol. 87, no. 11, pp. 1012-1018. https://doi.org/10.1161/01.RES.87.11.1012
Numaguchi H, Mullins FM, Johnson JP, Johns DC, Po SS, Yang ICH et al. Probing the interaction between inactivation gating and D-sotalol block of HERG. Circulation Research. 2000 Nov 24;87(11):1012-1018. https://doi.org/10.1161/01.RES.87.11.1012
Numaguchi, Hirotaka ; Mullins, Franklin M. ; Johnson, J. P. ; Johns, David C. ; Po, Sunny S. ; Yang, Iris C.H. ; Tomaselli, Gordon F. ; Balser, Jeffrey R. / Probing the interaction between inactivation gating and D-sotalol block of HERG. In: Circulation Research. 2000 ; Vol. 87, No. 11. pp. 1012-1018.
@article{7eccb158c9a140fea9f497568b7272a6,
title = "Probing the interaction between inactivation gating and D-sotalol block of HERG",
abstract = "Potassium channels encoded by HERG underlie I(Kr), a sensitive target for most class III antiarrhythmic drugs, including methanesulfonanilides such as D-sotalol. Recently it was shown that these drugs are trapped in the channel as it closes during hyperpolarization. At the same time, HERG channels rapidly open and inactivate when depolarized, and methanesulfonanilide block is known to develop in a use-dependent manner, suggesting a potential role for inactivation in drug binding. However, the role of HERG inactivation in class III drug action is uncertain: Pore mutations that remove inactivation reduce block, yet many of these mutations also modify the channel permeation properties and could alter drug affinity through gating-independent mechanisms. In the present study, we identify a definitive role for inactivation gating in D-Sotalol block of HERG, using interventions complementary to mutagenesis. These interventions (addition of extracellular Cd2+, removal of extracellular Na+) modify the voltage dependence of inactivation but not activation. In normal extracellular solutions, block of HERG current by 300/μmol/L D-sotalol reached 80{\%} after a 10-minute period of repetitive depolarization to +20 mV. Maneuvers that impeded steady-state inactivation also reduced D-sotalol block of HERG: 100 μmol/L Cd2+ reduced steady-state block to 55{\%} at +20 mV (P<0.05); removing extracellular Na+ reduced block to 44{\%} (P<0.05). An inactivation-disabling mutation (G628C-S631C) reduced D-sotalol block to only 11{\%} (P<0.05 versus wild type). However, increasing the rate of channel inactivation by depolarizing to +60 mV reduced D-sotalol block to 49{\%} (P<0.05 versus +20 mV), suggesting that the drug does not primarily bind to the inactivated state. Coexpression of MiRP1 with HERG had no effect on inactivation gating and did not modify D-sotalol block. We postulate that D-sotalol accesses its receptor in the open pore, and the drug-receptor interaction is then stabilized by inactivation. Whereas deactivation traps the bound methanesulfonanilide during hyperpolarization, we propose that HERG inactivation stabilizes the drug-receptor interaction during membrane depolarization.",
keywords = "Antiarrhythmic drugs, HERG, Inactivation, Potassium channel",
author = "Hirotaka Numaguchi and Mullins, {Franklin M.} and Johnson, {J. P.} and Johns, {David C.} and Po, {Sunny S.} and Yang, {Iris C.H.} and Tomaselli, {Gordon F.} and Balser, {Jeffrey R.}",
year = "2000",
month = "11",
day = "24",
doi = "10.1161/01.RES.87.11.1012",
language = "English (US)",
volume = "87",
pages = "1012--1018",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Probing the interaction between inactivation gating and D-sotalol block of HERG

AU - Numaguchi, Hirotaka

AU - Mullins, Franklin M.

AU - Johnson, J. P.

AU - Johns, David C.

AU - Po, Sunny S.

AU - Yang, Iris C.H.

AU - Tomaselli, Gordon F.

AU - Balser, Jeffrey R.

PY - 2000/11/24

Y1 - 2000/11/24

N2 - Potassium channels encoded by HERG underlie I(Kr), a sensitive target for most class III antiarrhythmic drugs, including methanesulfonanilides such as D-sotalol. Recently it was shown that these drugs are trapped in the channel as it closes during hyperpolarization. At the same time, HERG channels rapidly open and inactivate when depolarized, and methanesulfonanilide block is known to develop in a use-dependent manner, suggesting a potential role for inactivation in drug binding. However, the role of HERG inactivation in class III drug action is uncertain: Pore mutations that remove inactivation reduce block, yet many of these mutations also modify the channel permeation properties and could alter drug affinity through gating-independent mechanisms. In the present study, we identify a definitive role for inactivation gating in D-Sotalol block of HERG, using interventions complementary to mutagenesis. These interventions (addition of extracellular Cd2+, removal of extracellular Na+) modify the voltage dependence of inactivation but not activation. In normal extracellular solutions, block of HERG current by 300/μmol/L D-sotalol reached 80% after a 10-minute period of repetitive depolarization to +20 mV. Maneuvers that impeded steady-state inactivation also reduced D-sotalol block of HERG: 100 μmol/L Cd2+ reduced steady-state block to 55% at +20 mV (P<0.05); removing extracellular Na+ reduced block to 44% (P<0.05). An inactivation-disabling mutation (G628C-S631C) reduced D-sotalol block to only 11% (P<0.05 versus wild type). However, increasing the rate of channel inactivation by depolarizing to +60 mV reduced D-sotalol block to 49% (P<0.05 versus +20 mV), suggesting that the drug does not primarily bind to the inactivated state. Coexpression of MiRP1 with HERG had no effect on inactivation gating and did not modify D-sotalol block. We postulate that D-sotalol accesses its receptor in the open pore, and the drug-receptor interaction is then stabilized by inactivation. Whereas deactivation traps the bound methanesulfonanilide during hyperpolarization, we propose that HERG inactivation stabilizes the drug-receptor interaction during membrane depolarization.

AB - Potassium channels encoded by HERG underlie I(Kr), a sensitive target for most class III antiarrhythmic drugs, including methanesulfonanilides such as D-sotalol. Recently it was shown that these drugs are trapped in the channel as it closes during hyperpolarization. At the same time, HERG channels rapidly open and inactivate when depolarized, and methanesulfonanilide block is known to develop in a use-dependent manner, suggesting a potential role for inactivation in drug binding. However, the role of HERG inactivation in class III drug action is uncertain: Pore mutations that remove inactivation reduce block, yet many of these mutations also modify the channel permeation properties and could alter drug affinity through gating-independent mechanisms. In the present study, we identify a definitive role for inactivation gating in D-Sotalol block of HERG, using interventions complementary to mutagenesis. These interventions (addition of extracellular Cd2+, removal of extracellular Na+) modify the voltage dependence of inactivation but not activation. In normal extracellular solutions, block of HERG current by 300/μmol/L D-sotalol reached 80% after a 10-minute period of repetitive depolarization to +20 mV. Maneuvers that impeded steady-state inactivation also reduced D-sotalol block of HERG: 100 μmol/L Cd2+ reduced steady-state block to 55% at +20 mV (P<0.05); removing extracellular Na+ reduced block to 44% (P<0.05). An inactivation-disabling mutation (G628C-S631C) reduced D-sotalol block to only 11% (P<0.05 versus wild type). However, increasing the rate of channel inactivation by depolarizing to +60 mV reduced D-sotalol block to 49% (P<0.05 versus +20 mV), suggesting that the drug does not primarily bind to the inactivated state. Coexpression of MiRP1 with HERG had no effect on inactivation gating and did not modify D-sotalol block. We postulate that D-sotalol accesses its receptor in the open pore, and the drug-receptor interaction is then stabilized by inactivation. Whereas deactivation traps the bound methanesulfonanilide during hyperpolarization, we propose that HERG inactivation stabilizes the drug-receptor interaction during membrane depolarization.

KW - Antiarrhythmic drugs

KW - HERG

KW - Inactivation

KW - Potassium channel

UR - http://www.scopus.com/inward/record.url?scp=0034711465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034711465&partnerID=8YFLogxK

U2 - 10.1161/01.RES.87.11.1012

DO - 10.1161/01.RES.87.11.1012

M3 - Article

C2 - 11090546

AN - SCOPUS:0034711465

VL - 87

SP - 1012

EP - 1018

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 11

ER -